A Natural History Study of Patients With Dry Eye
NCT00833235 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 284
Last updated 2017-07-25
Summary
This is a multi-center, prospective, controlled, observational study of the natural history of patients with dry eye disease.
Conditions
- Dry Eye
Interventions
- OTHER
-
Artificial Tears
Artificial tears (any brand) may be used to treat dry eye symptoms.
Sponsors & Collaborators
-
Allergan
lead INDUSTRY
Principal Investigators
-
Tes Ignacio · Allergan
Eligibility
- Min Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-02-01
- Primary Completion
- 2017-03-06
- Completion
- 2017-03-06
Countries
- United States
Study Locations
More Related Trials
-
A Study to Investigate the Effect of 0.003% AR-15512 on Subjects With Dry Eye Disease
NCT06544694 ·Status: COMPLETED ·Phase: PHASE3
-
ACCURATE Study for Subjects With Dry Eyes
NCT04237012 ·Status: COMPLETED ·Phase: PHASE4
-
A Retrospective Analysis of Restasis® Benefits in Dry Eye Contact Lens Patients
NCT02522312 ·Status: COMPLETED
-
Evaluating Patients With Eye Allergies and Determining if There Are Also Dry Eyes
NCT01679015 ·Status: COMPLETED
-
Evaluation of the Effect of Repeated Usage on the Tear Film Characteristics of an Investigational Eye Drop in Dry Eye Sufferers
NCT01339936 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Assessment of Inflammatory and Functional Changes in the Ocular Surface Associated With Dry Eye Disease
NCT00809003 ·Status: COMPLETED
-
Impairment of Reading Ability in Dry Eye Patients
NCT01826812 ·Status: COMPLETED
-
Pilot Study of TearCare System - Long-Term Extension
NCT03804502 ·Status: COMPLETED ·Phase: NA
-
Assessment of Tear Film Thickness by Optical Coherence Tomography in Healthy Subjects and Subjects With Dry Eye Disease
NCT01753596 ·Status: WITHDRAWN ·Phase: PHASE3
-
Correlation of Different Signs for Assessment of Dry Eye Syndrome
NCT01753687 ·Status: COMPLETED ·Phase: NA
-
Investigation on Medical Management of Dry Eye Patients
NCT01942226 ·Status: COMPLETED
-
Influencing Factors on Dry Eye Syndrome and Ocular Surface Disease
NCT03364322 ·Status: COMPLETED
-
A Study Assessing the Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients
NCT01468168 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of the Chronic Application of Tear Formulations
NCT01384851 ·Status: UNKNOWN ·Phase: NA
-
Clinical Efficacy of H.P. Acthar Gel 80 U/ml to Improve the Signs and Symptoms in Subjects With Dry Eye Disease
NCT03287635 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Ocular Comfort With ISTA Tears vs Systane
NCT01650584 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Two Artificial Tears in Dry Eye Subjects
NCT01010282 ·Status: COMPLETED ·Phase: NA
-
Trial of CF101 to Treat Patients With Dry Eye Disease
NCT01235234 ·Status: COMPLETED ·Phase: PHASE3
-
Closed Eye Neutrophils in Dry Eye Disease
NCT03332342 ·Status: COMPLETED ·Phase: NA
-
Tear Dynamics After Restasis Treatment in Dry Eye Patients
NCT00706940 ·Status: COMPLETED
-
DRy Eye Outcome and Prescription Study
NCT03652415 ·Status: UNKNOWN
-
Study of the Safety and Tolerability of P 321 Ophthalmic Solution in Subjects With Dry Eye Disease
NCT02242032 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of an Artificial Tear for the Treatment of Dry Eye
NCT00514852 ·Status: COMPLETED ·Phase: NA
-
Lipids of the Human Tear Film and Their Effect on Tear Stability
NCT00803452 ·Status: COMPLETED ·Phase: PHASE4
-
A Dose Regimen Study of BRM421 Ophthalmic Solution in Patients With Dry Eye Disease
NCT07078955 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2